Takeda Pharmaceutical Company Limited Repayments Of Borrowings Classified As Financing Activities
Takeda Pharmaceutical Company Limited (TKPHF) reported Repayments Of Borrowings Classified As Financing Activities of JPY 1.32 trillion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities · last filed 2025-06-25
| Period end | Repayments Of Borrowings Classified As Financing Activities 12 month |
|---|---|
| 2025-03-31 | 1.32T JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 320.90B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 356.67B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 810.12B JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | 1.65T JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | 701.06B JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | 0.00 JPY 20-F · filed 2021-06-29 |
| 2018-03-31 | 140.00B JPY 20-F · filed 2020-06-24 |
| 2017-03-31 | 191.76B JPY 20-F · filed 2019-06-27 |